// App-Quantinova.ai

: Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation for Therapy-Related Myeloid Neoplasms Following Treatment for Myeloma

Researchers

Presenter

  • Sarah Lawless

Principal Investigators

  • Dirk-Jan Eikema

  • Linda Kostner

  • Friedrich Stoelzel

  • Nicolaus Kroger

  • Uwe Platzbecker

  • Wolfgang Bethge

  • Peter Brossart

  • Renato Fanin

  • Jurgen Finke

  • Jurgen Kuball

  • Veronique Leblond

  • Emma Nicholson

  • Jakob Passweg

  • Daniele Avenoso

  • Jacques-Olivier Bay

  • Ali Bazarbachi

  • Dolores Caballero

  • Joanna Drozd-Sokolowska

  • Christof Scheid

  • Donal P. McLornan

  • Marie Robin

  • Ibrahim Yakoub-Agha

Medical Centers

  • The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Queens University of Belfast, Belfast, United Kingdom

  • Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany

  • Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

  • Department of Hematology, UMC Utrecht, Utrecht, Netherlands

  • Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, CIO ABCD, Germany

  • Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany

  • Department of Statistics, Leiden University Medical Centre, Leiden, Netherlands

  • Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany

  • Hematology & Oncology, Universitaet Tuebingen, Medizinische Klinik, Tuebingen, Germany

  • University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany

  • Department of Hematology and Cell Therapy, Estaing University Hospital, CLERMONT-FERRAND, France

  • EBMT Statistical Unit, Leiden, Netherlands

  • Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland

  • Département d’ Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France

  • Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany

  • Medical Clinic and Policlinic , Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

  • EBMT Leiden Study Unit, Leiden, Netherlands

  • Belfast City Hospital, Belfast, United Kingdom

  • Department of Haematology, Kings's College Hospital, London, United Kingdom

  • Kings College Hospital, London, GBR

  • Instituto de Investigacion Biomedica de Salamanca (IBSAL), Salamanca, Spain

  • Centre Hospitalier Universitaire de Lille LIRIC, INSERM U, Université de Lille, Lille, France

  • Division of Hematology, University Hospital Basel, Basel, Switzerland

  • Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany

  • Hopital Saint Louis, APHP, Université de Paris Cité, Paris, FRA

  • Division of Hematology, Udine University Hospital, Udine, Italy

Locations

  • United Kingdom

  • Netherlands

  • France

  • Spain

  • Germany

  • Switzerland

  • Lebanon

  • United States

  • Italy

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved